Oramed Pharma (ORMP) Screens First Patient in ORMD-0801 Phase 2b
Tweet Send to a Friend
Oramed Pharma (Nasdaq: ORMP) announced that the first patient has been screened in the Company's Phase IIb trial of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE